The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1

Eur J Cancer. 1995;31A(3):420-1. doi: 10.1016/0959-8049(94)00524-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Breast Neoplasms / blood*
  • Female
  • Fenretinide / pharmacology*
  • Humans
  • Insulin-Like Growth Factor I / drug effects*
  • Middle Aged
  • Tretinoin / analogs & derivatives*
  • Tretinoin / blood

Substances

  • Fenretinide
  • Tretinoin
  • Insulin-Like Growth Factor I
  • N-(4-methoxyphenyl)retinamide